Zhang Boli and other seven academicians "gathered" Shijiazhuang to talk about the transformation of the innovation achievements of Chinese medicine

Great Wall Network · Jiyun Client July 6th (Reporter Yan Group Zhang Jianxun) On the morning of July 6, "Shouzheng Innovation to the Future • Converting Summit Forum of TCM Research and Innovation Achievements" was held in Shijiazhuang, Zhang Boli, Cong Bin , Zhang Yun, Yang Baofeng, Yu Jinming, Tian Jinzhou, Wu Yiling and other academicians, as well as Li Yigui, a master of Chinese medicine, gathered together with experts and scholars in the Chinese medicine industry across the country through online and offline ways, surrounding the theoretical inheritance, innovation, and transformation around the theoretical theory of neat disease theory The important achievements achieved in -depth exchanges.

Summit forum scene. Great Wall Network · Jiyun Client reporter Yanyu Group Photo

After more than 40 years of concentration research, Wu Yiling, an academician of the Chinese Academy of Engineering, has stretched the "List disease" in the history of the Chinese national medicine for nearly three thousand years. System theory of treatment value of cure diseases. Under this theoretical guidance, 13 new patent drugs for innovation patent were developed, and the transformation of the series of results was completed. The academic exchange platforms at home and abroad have formed a wave of theory research at home and abroad.

Zhang Boli, an academician of the Chinese Academy of Engineering, was interviewed. Photo by Zhang Jianxun, a reporter from Great Wall Network · Jiyun Client

In the academician salon session, Zhang Boli, Cong Bin, Zhang Yun, Yang Baofeng, Yu Jinming, Tian Jinzhou and other academicians, as well as well -known clinical experts Zhao Jiajun and Zhu Mingjun through online and offline ways to transform "through traditional Chinese medicine theory and innovation achievements. The development of traditional Chinese medicine "developed in -depth discussions. Academic theory is the endogenous force of the development of traditional Chinese medicine, which has become an inexhaustible driving force and core technology that promotes the innovation and development of traditional Chinese medicine. As one of the typical representatives of traditional Chinese medicine inheritance and innovation in the new period, the research of traditional Chinese medicine has created a model of "theory+clinical+new medicine+experiment+evidence", setting a model for traditional Chinese medicine inheritance innovation.

Academician salon session. Photo by Zhang Jianxun, a reporter from Great Wall Network · Jiyun Client

Zhang Boli, an academician of the Chinese Academy of Engineering and the national honorary title of the "People's Heroes", said that the theoretical system of linked pathology is the fourth milestone in the history of traditional Chinese medicine, an important achievement of the modernization of traditional Chinese medicine, and a model of inheritance and innovation of traditional Chinese medicine. Under the guidance of the theoretical of the neutral disease, Yiling Pharmaceutical developed a number of Tongluo drugs such as Tongxinluo Capsules, Ginseng Yangxin Capsules, and Lianhua Qing Plague Capsules (granules). It has achieved good results in the prevention and treatment of major clinical diseases.

Jia Zhenhua, the president of Hebei Yiling Hospital and the dean of Hebei Province Traditional Chinese and Western Medicine Research Institute, believes that evidence -based medicine is the world's recognized scientific evaluation "gold standard". More than 30 evidence -based studies, covering cardiovascular and cerebrovascular diseases, diabetes, respiratory diseases, tumors, neurological diseases, urinary system diseases, and other six major types of diseases for diseases. Evidence support.

Wu Yiling, an academician of the Chinese Academy of Engineering, made a report. Great Wall Network · Jiyun Client reporter Yanyu Group Photo

In recent years, Shijiazhuang City has relied on the strong development of traditional Chinese medicine, a complete Chinese medicine service system, and a complete Chinese medicine industry chain. A series of policies have been introduced to push the modernization and industrialization of traditional Chinese medicine. "Shijiazhuang High -tech Zone will take this forum as an opportunity to strengthen the connection with high -level experts and talents, fully tap high -quality enterprise resources such as Ling Pharmaceutical and Shi Pharmaceutical Group, and further increase support for the biomedical industries such as innovative Chinese medicine. , Ding Feiyan, a member of the Working Committee of Shijiazhuang High -tech Zone and Director of the Management Office of the Science and Technology Pioneering Park Management Park, said extensively.

The forum was jointly sponsored by the Management Committee of Shijiazhuang High -tech Industrial Development Zone, Hebei Pharmaceutical Society, Hebei Medical Industry Association, and World Chinese Medicine Association Joint Association.

- END -